tiprankstipranks
Synairgen plc (GB:SNG)
:SNG
Holding GB:SNG?
Track your performance easily

Synairgen (SNG) Share Price & Analysis

17 Followers

SNG Stock Chart & Stats


Financials

Annual

SNG FAQ

What was Synairgen plc’s price range in the past 12 months?
Synairgen plc lowest share price was 1.80p and its highest was 7.22p in the past 12 months.
    What is Synairgen plc’s market cap?
    Synairgen plc’s market cap is £9.99M.
      When is Synairgen plc’s upcoming earnings report date?
      Synairgen plc’s upcoming earnings report date is Mar 13, 2025 which is in 54 days.
        How were Synairgen plc’s earnings last quarter?
        Synairgen plc released its earnings results on Sep 26, 2024. The company reported -0.012p earnings per share for the quarter, missing the consensus estimate of N/A by -0.012p.
          Is Synairgen plc overvalued?
          According to Wall Street analysts Synairgen plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Synairgen plc pay dividends?
            Synairgen plc does not currently pay dividends.
            What is Synairgen plc’s EPS estimate?
            Synairgen plc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Synairgen plc have?
            Synairgen plc has 501,410,700 shares outstanding.
              What happened to Synairgen plc’s price movement after its last earnings report?
              Synairgen plc reported an EPS of -0.012p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.643%.
                Which hedge fund is a major shareholder of Synairgen plc?
                Currently, no hedge funds are holding shares in GB:SNG
                ---

                Company Description

                Synairgen plc

                Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, LOXL2 inhibitor, and others.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                ANGLE plc
                PureTech Health
                Avacta Group plc
                Open Orphan Plc
                Genedrive
                Oncimmune Holdings
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis